Celltrion
068270.KS
#741
Rank
โ‚น2.272 T
Marketcap
โ‚น10,558
Share price
0.33%
Change (1 day)
-23.80%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚น2.272 Trillion

As of January 2025 Celltrion has a market cap of โ‚น2.272 Trillion. This makes Celltrion the world's 741th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น2.272 T0.36%
2024โ‚น2.263 T-18.78%
2023โ‚น2.787 T85.78%
2022โ‚น1.500 T-13.07%
2021โ‚น1.725 T-47.67%
2020โ‚น3.297 T132.25%
2019โ‚น1.419 T-18.24%
2018โ‚น1.736 T5.66%
2017โ‚น1.643 T122.48%
2016โ‚น738.73 B37.54%
2015โ‚น537.10 B134%
2014โ‚น229.53 B4.15%
2013โ‚น220.37 B-7.37%
2012โ‚น237.92 B23.17%
2011โ‚น193.16 B25.04%
2010โ‚น154.47 B152.45%
2009โ‚น61.19 B57.84%
2008โ‚น38.76 B5187.57%
2007โ‚น0.73 B

End of Day market cap according to different sources

On Jan 4th, 2025 the market cap of Celltrion was reported to be:

โ‚น2.269 Trillion
by Yahoo Finance info icon info icon
โ‚น2.272 Trillion
by CompaniesMarketCap info icon info icon